Basit öğe kaydını göster

dc.contributor.authorKatrinli, Şeyma
dc.contributor.authorÖzdil, Kamil
dc.contributor.authorŞahin, Aslı
dc.contributor.authorÖztürk, Oğuzhan
dc.contributor.authorKır, Gözde
dc.contributor.authorBaykal, Ahmet Tarık
dc.contributor.authorSaraç, Ömer Sinan
dc.contributor.authorSökmen, Mehmet
dc.contributor.authorDinler Doğanay, Gizem
dc.contributor.authorDoğanay, Hamdi Levent
dc.date.accessioned10.07.201910:49:13
dc.date.accessioned2019-07-10T19:58:15Z
dc.date.available10.07.201910:49:13
dc.date.available2019-07-10T19:58:15Z
dc.date.issued2016en_US
dc.identifier.citationKatrinli, Ş., Özdil, K., Şahin, A., Öztürk, O., Kır, G., Baykal, A. T. ... Doğanay, H. L. (2016). Determination of stage specific markers for liver fibrosis in hepatitis B: A comparative tissue proteomic study. EASL International Liver Congress içinde (S446-S446. ss.). Barcelona, Spain, April 13-17, 2016. https://dx.doi.org/10.1016/S0168-8278(16)00738-8en_US
dc.identifier.issn0168-8278
dc.identifier.issn1600-0641
dc.identifier.urihttps://dx.doi.org/10.1016/S0168-8278(16)00738-8
dc.identifier.urihttps://hdl.handle.net/20.500.12511/3135
dc.descriptionEASL International Liver Congress -- APR 13-17, 2016 -- Barcelona, SPAINen_US
dc.descriptionWOS: 000398711700732en_US
dc.description.abstractBackground and Aims: Chronic Hepatitis B infection is one of themajor causes of liver cirrhosis and around 600,000 people dieannually worldwide. The virus itself is non-cytopathic and the liverdamage is due to host immune reaction. Thus liver damage pathwaysmight differ in chronic HBV and comprehensive tissue proteomicanalysis is missing in literature. To estimate which patient withchronic hepatitis B will develop rapidly fibrosis or cirrhosis is yet athorny issue and requires a vast recognition of cellular pathwaysinvolved in fibrosis. The aim of this study is to enlighten pathwaysassociated with liver fibrosis in HBV infection for leading up to newtherapeutic targets and diagnostic biomarkers.en_US
dc.description.sponsorshipEASLen_US
dc.language.isoengen_US
dc.publisherElsevier Science B.V.en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectHepatitis Ben_US
dc.subjectLiver Fibrosisen_US
dc.subjectSpecific Markersen_US
dc.titleDetermination of stage specific markers for liver fibrosis in hepatitis B: A comparative tissue proteomic studyen_US
dc.typeconferenceObjecten_US
dc.relation.ispartofEASL International Liver Congressen_US
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü, Tıbbi Biyokimya Ana Bilim Dalıen_US
dc.identifier.volume64en_US
dc.identifier.issueSupplement: 2en_US
dc.identifier.startpageS446en_US
dc.identifier.endpageS446en_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.1016/S0168-8278(16)00738-8en_US
dc.identifier.wosqualityQ1en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster